- Home
- KRYS vs BEP Comparison
KRYS vs BEP Comparison
Compare KRYS & BEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRYS | BEP |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | Canada |
| Employees | 295 | 5870 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 10.3B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | KRYS | BEP |
|---|---|---|
| Price | $344.64 | $32.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $297.60 | $35.70 |
| AVG Volume (30 Days) | 548.4K | ★ 1.0M |
| Earning Date | 05-04-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.71% |
| EPS Growth | ★ 128.00 | N/A |
| EPS | ★ 1.83 | N/A |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $38.74 | $17.09 |
| Revenue Next Year | $32.53 | N/A |
| P/E Ratio | $199.26 | ★ N/A |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $130.50 | $24.13 |
| 52 Week High | $382.54 | $38.12 |
Technical Indicators
Market Signals| Indicator | KRYS | BEP |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 46.99 |
| Support Level | $246.17 | $31.84 |
| Resistance Level | $382.33 | $34.47 |
| Average True Range (ATR) | 18.24 | 1.00 |
| MACD | -0.46 | 0.11 |
| Stochastic Oscillator | 53.10 | 50.56 |
Price Performance
Historical ComparisonAbout KRYS Krystal Biotech Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
About BEP Brookfield Renewable Partners L.P.
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.